Overview

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

Status:
RECRUITING

Trial end date:
2028-11-27

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma (FL).

Phase:

PHASE2

Details

Lead Sponsor:

Celgene

Treatments:

1-dodecylpyridoxal
Bendamustine Hydrochloride
Cyclophosphamide
Doxorubicin
liposomal doxorubicin
Prednisone
Rituximab
Vincristine